Market Overview

Mid-Morning Market Update: Markets Mixed; Apple Earnings Top Expectations

Share:

Following the market opening Wednesday, the Dow traded down 0.20 percent to 24,049.80 while the NASDAQ climbed 0.28 percent to 7,150.41. The S&P also fell, dropping 0.15 percent to 2,650.78.

Leading and Lagging Sectors

Wednesday morning, the information technology shares rose 0.63 percent. Meanwhile, top gainers in the sector included Nanometrics Incorporated (NASDAQ: NANO), up 26 percent, and MACOM Technology Solutions Holdings, Inc. (NASDAQ: MTSI) up 23 percent.

In trading on Wednesday, consumer staples shares tumbled 1.06 percent.

Top Headline

Apple Inc (NASDAQ: AAPL) reported better-than-expected earnings for its second-quarter earnings.

The world’s largest company, the tech giant delivered second-quarter earnings of $2.73, beating estimates by 3 cents. Sales came in at $61.1 billion, slightly above estimates.

Apple also announced a new $100 billion buyback plan and raised its quarterly dividend by 16 percent from 63 cents per share to 73 cents per share. Apple issued third-quarter sales guidance of $51.5 billion-$53.3 billion, against a $52 billion estimate.

Equities Trading UP

HC2 Holdings, Inc. (NYSE: HCHC) shares shot up 35 percent to $7.00 after the company disclosed that BeneVir Biopharm agreed to be purchased by J&J's Janssen Biotech for up to $1.04 billion.

Shares of MACOM Technology Solutions Holdings, Inc. (NASDAQ: MTSI) got a boost, shooting up 22 percent to $21.41 after reporting upbeat quarterly results.

Nanometrics Incorporated (NASDAQ: NANO) shares were also up, gaining 26 percent to $33.139 after reporting better-than-expected Q1 earnings.

Equities Trading DOWN

Command Security Corporation (NYSE: MOC) shares dropped 22 percent to $2.24 after the company reported a loss of a significant contract.

Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) were down 22 percent to $55.05 after reporting a wider-than-expected Q1 loss. Esperion disclosed that top-line results from pivotal Phase 3 long-term safety study of bempedoic acid met primary endpoint.

Heat Biologics, Inc. (NASDAQ: HTBX) was down, falling around 25 percent to $3.11. The nano-cap biotechnology saw its stock soar 87 percent throughout Monday's session and was higher by more than 120 percent at one point. There was no company specific news to support the volatility, but the movement could be attributed to recent trader interest in "low float stocks." In Heat Biologics case, there are approximately 5.6 million shares outstanding.

Commodities

In commodity news, oil traded down 0.07 percent to $67.20 while gold traded down 0.11 percent to $1,305.40.

Silver traded up 1.51 percent Wednesday to $16.37, while copper rose 0.89 percent to $3.0645.

Eurozone

European shares were higher today. The eurozone’s STOXX 600 rose 0.56 percent, the Spanish Ibex Index rose 0.98 percent, while Italy’s FTSE MIB Index rose 1.01 percent. Meanwhile the German DAX rose 1.39 percent, and the French CAC 40 climbed 0.14 percent while U.K. shares rose 0.38 percent.

Economics

Private-sector employers added 204,000 jobs in April, Automatic Data Processing Inc. reported. Economists expected a gain of 190,000 jobs.

The Energy Information Administration’s weekly report on petroleum inventories in the U.S. is schedule for release at 10:30 a.m. ET.

The Federal Open Market Committee will announce its policy decision at 2:00 p.m. ET.

Posted-In: Mid-Morning Market UpdateNews Eurozone Commodities Global Intraday Update Markets

 

Related Articles (AAPL + ESPR)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Online Retail ETF Celebrates Second Anniversary In Style

Apple's Results Digested As Investors Await Latest Word From Fed